You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-L1 (programmed cell death ligand 1)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Non-small Cell Carcinoma, NSCLC Trial (Ramucirumab, Atezolizumab, N-803)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 28, 2021

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Healthy Adult Subjects Trial in Sydney (TNM002 Dosage 1 (10 µg/kg), Placebo, TNM002 Dosage 2 (35 µg/kg))

Completed
  • Healthy Adult Subjects
  • TNM002 Dosage 1 (10 μg/kg)
  • +4 more
  • Sydney, New South Wales, Australia
    Scientia Clinical Research
Nov 2, 2022

GVHD Trial in Worldwide (INC424)

Active, not recruiting
  • Graft vs Host Disease
  • Sao Paulo, Brazil
  • +20 more
Oct 26, 2022

Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™

Recruiting
  • Mouth Diseases
  • STRATICYTE™ Test
  • Birmingham, Alabama
  • +3 more
May 2, 2023

Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +1 more
Jan 31, 2023

Metastatic Breast Cancer Trial in Dallas (Anakinra plus Standard of Care)

Completed
  • Metastatic Breast Cancer
  • Anakinra plus Standard of Care
  • Dallas, Texas
    Baylor University Medical Center
Oct 7, 2021

Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)

Active, not recruiting
Has Results
  • Esophageal Cancer
  • +2 more
  • Boston, Massachusetts
  • +2 more
Apr 7, 2022

Preeclampsia, Obstetric Labor Complications, Hypertension in Pregnancy Trial in United States (Pravastatin, Placebo)

Active, not recruiting
  • Preeclampsia
  • +2 more
  • Birmingham, Alabama
  • +11 more
Dec 19, 2022

NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Non-small Cell Lung Cancer
  • Jette, Brussel, Belgium
    Universitair Ziekenhuis Brussel
Jun 27, 2023

Severe Traumatic Brain Injury Trial in Worldwide (ICP, CREVICE)

Not yet recruiting
  • Severe Traumatic Brain Injury
  • ICP
  • CREVICE
  • Seattle, Washington
  • +8 more
Oct 1, 2022

Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

Recruiting
  • Neoplasm, Plasma Cell
  • Lymphoma
  • Comprehensive Geriatric Assessment
  • Toulouse, France
    University Hospital Toulouse
Oct 12, 2022

NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Busan, Korea, Republic of
    Pusan National University Hospital
Apr 3, 2023

Metastatic Carcinoma in the Adrenal Cortex, Recurrent Adrenal Cortex Carcinoma, Stage III Adrenal Cortex Carcinoma Trial in

Terminated
Has Results
  • Metastatic Carcinoma in the Adrenal Cortex
  • +3 more
  • Chicago, Illinois
  • +1 more
Apr 11, 2019

Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

Not yet recruiting
  • Relapsing Remitting Multiple Sclerosis
  • PIPE-307 Dose A
  • +2 more
  • (no location specified)
Oct 9, 2023

Ewing Sarcomas, Chondrosarcomas, Osteosarcomas Trial in France (Regorafenib, Placebo)

Recruiting
  • Ewing Sarcomas
  • +4 more
  • Besancon, France
  • +18 more
Apr 1, 2022

Real-world Setting: Preliminary Analysis From Select Sickle Cell

Completed
  • Sickle Cell Disease
    • Birmingham, Alabama
    • +10 more
    Apr 17, 2023

    Mild to Moderate COVID-19 Trial in China, Hong Kong (JT001, Placebo)

    Recruiting
    • Mild to Moderate COVID-19
    • Chongqing, Chongqing, China
    • +7 more
    Apr 4, 2022

    SARS-CoV-2 Trial in Beijing (1 week (Week 1), 1 week of probiotics(Week 1), 1 week (Week 2))

    Recruiting
    • SARS-CoV-2
    • 1 week placebo(Week 1)
    • +5 more
    • Beijing, China
    • +1 more
    Jul 3, 2022

    Healthy Adult Subjects, Sickle Cell Disease Trial in Little Rock, Atlanta, Overland Park (FTX-6058/ oral capsule(s), FTX-6058 -

    Completed
    • Healthy Adult Subjects
    • Sickle Cell Disease
    • FTX-6058/placebo oral capsule(s)
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Dec 9, 2022

    Tachycardia, Ventricular Arrythmia Trial (Defibrillation using the Extravascular ICD)

    Not yet recruiting
    • Tachycardia
    • Ventricular Arrythmia
    • Defibrillation using the Extravascular ICD
    • (no location specified)
    Jun 24, 2022

    FFPE Samples From Younger Patients With Rhabdomyosarcoma

    Completed
    • Alveolar Childhood Rhabdomyosarcoma
    • +2 more
      • Jinan, Shandong, China
        Jinan central hospital affiliated to Shandong First Medical Univ
      Sep 10, 2023

      Long Term Impact of COVID-19

      Active, not recruiting
      • Long COVID-19
      • +2 more
      • Observational patient reported outcomes
      • Enschede, Overijssel, Netherlands
        Medisch Spectrum Twente
      Apr 14, 2023

      Postmenopausal Osteoporosis Trial in Poland (SB16 (Proposed Denosumab Biosimilar), Prolia® (Denosumab))

      Active, not recruiting
      • Postmenopausal Osteoporosis
      • SB16 (Proposed Denosumab Biosimilar)
      • Prolia® (Denosumab)
      • Kraków, Poland
      • +4 more
      Oct 13, 2021

      Chronic Kidney Disease Stage V Trial (Inteligent Dialysis Assistant (IDA))

      Not yet recruiting
      • Chronic Kidney Disease Stage V
      • Inteligent Dialysis Assistant (IDA)
      • (no location specified)
      Apr 18, 2022